113 related articles for article (PubMed ID: 25341273)
21. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
22. [Effects of leukotriene receptor antagonists on vascular endothelial growth factor and its receptors in a sensitized rat model].
Yang HS; Wang L; Yang W; Guan JT; Ma JY; Su Y
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Mar; 32(3):177-81. PubMed ID: 19575935
[TBL] [Abstract][Full Text] [Related]
23. Diesel exhaust particles in the lung aggravate experimental acute renal failure.
Nemmar A; Al-Salam S; Zia S; Yasin J; Al Husseni I; Ali BH
Toxicol Sci; 2010 Jan; 113(1):267-77. PubMed ID: 19797351
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner.
Ozyurt H; Yildirim Z; Kotuk M; Yilmaz HR; Yağmurca M; Iraz M; Söğüt S; Gergerlioglu S
J Appl Toxicol; 2004; 24(4):269-75. PubMed ID: 15300714
[TBL] [Abstract][Full Text] [Related]
25. Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats.
Al-Shabanah OA; Aleisa AM; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Fatani AG; Sayed-Ahmed MM
Nephrol Dial Transplant; 2010 Jan; 25(1):69-76. PubMed ID: 19737869
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of melatonin versus montelukast in cisplatin-induced seminiferous tubule damage in rats.
El-Shafaei A; Abdelmaksoud R; Elshorbagy A; Zahran N; Elabd R
Andrologia; 2018 Nov; 50(9):e13077. PubMed ID: 30019386
[TBL] [Abstract][Full Text] [Related]
27. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
28. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
29. Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotoxicity.
Aydinoz S; Uzun G; Cermik H; Atasoyu EM; Yildiz S; Karagoz B; Evrenkaya R
Ren Fail; 2007; 29(3):257-63. PubMed ID: 17497437
[TBL] [Abstract][Full Text] [Related]
30. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.
Kanki M; Moriguchi A; Sasaki D; Mitori H; Yamada A; Unami A; Miyamae Y
Toxicology; 2014 Oct; 324():158-68. PubMed ID: 24863737
[TBL] [Abstract][Full Text] [Related]
31. Montelukast influence on kidney in experimental induced diabetes mellitus.
Gales C; Stoica B; Nechifor M; Rusu-Zota G
Pak J Pharm Sci; 2023 Mar; 36(2):507-513. PubMed ID: 37530159
[TBL] [Abstract][Full Text] [Related]
32. Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast.
Kabasakal L; Sener G; Cetinel S; Contuk G; Gedik N; Yeğen BC
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):431-40. PubMed ID: 15890506
[TBL] [Abstract][Full Text] [Related]
33. Cysteinyl leukotrienes predominantly mediate cisplatin-induced acute renal damage in male rats.
Hashim AA; Helmy MM; Mouneir SM
J Physiol Pharmacol; 2018 Oct; 69(5):. PubMed ID: 30683829
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.
Suddek GM; El-Kenawi AE; Abdel-Aziz A; El-Kashef HA
Chemotherapy; 2011; 57(4):321-6. PubMed ID: 21893983
[TBL] [Abstract][Full Text] [Related]
35. Effects of montelukast on the healing of ischemic colon anastomoses.
Celik A; Ergun E; Koksal N; Celik AS; Altinli E; Uzun MA; Eroglu E; Kemik A
Am J Surg; 2013 Oct; 206(4):502-8. PubMed ID: 23809995
[TBL] [Abstract][Full Text] [Related]
36. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa.
Sener G; Kapucu C; Cetinel S; Cikler E; Ayanoğlu-Dülger G
Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):1-11. PubMed ID: 15589394
[TBL] [Abstract][Full Text] [Related]
37. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Cikler E; Ersoy Y; Cetinel S; Ercan F
Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of urinary kidney injury molecule-1 (Kim-1) as a biomarker for cisplatin-induced sub-chronic kidney injury.
Nan-Ya K; Kajihara M; Kojima N; Degawa M
J Appl Toxicol; 2015 Feb; 35(2):124-32. PubMed ID: 24737228
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.
Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE
Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477
[TBL] [Abstract][Full Text] [Related]
40. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
Zhou C; Shi X; Huang H; Zhu Y; Wu Y
Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]